Real-world dry eye study shows long-term efficacy of cyclosporine A 0.1% cationic emulsion

Real-world outcomes from the PERSPECTIVE study showed long-term efficacy of cyclosporine A 0.1% cationic emulsion in controlling severe keratitis in patients with dry eye disease.
The study was conducted in 44 clinics across Europe and included 472 patients with dry eye disease (DED) who were nonresponsive to previous treatment with artificial tears. Corneal fluorescein staining (CFS) score was significantly reduced at all study visits from week 4 through month 12.
“DED is an increasingly common condition that affects approximately 11% to 30% of people in Europe and has a heavy impact on

Real-world outcomes from the PERSPECTIVE study showed long-term efficacy of cyclosporine A 0.1% cationic emulsion in controlling severe keratitis in patients with dry eye disease.
The study was conducted in 44 clinics across Europe and included 472 patients with dry eye disease (DED) who were nonresponsive to previous treatment with artificial tears. Corneal fluorescein staining (CFS) score was significantly reduced at all study visits from week 4 through month 12.
“DED is an increasingly common condition that affects approximately 11% to 30% of people in Europe and has a heavy impact on